DAISY GEATHERS: Open Payments
NPI 1114624780 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 32 payments from 8 companies in 2025. Trend: 2023 $97 · 2024 $321 · 2025 $722
Food & beverage: $610Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $215 |
| Braeburn Inc. | 2 | $154 |
| Janssen Pharmaceuticals, Inc | 11 | $141 |
| Alkermes, Inc. | 3 | $62 |
| Indivior Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
Products named: BRIXADI, UZEDY, INVEGA SUSTENNA, ARISTADA, SPRAVATO, SUBLOCADE, CAPLYTA, REXULTI.
Industry payments across CT — which companies pay providers there.
